FDA Granted Pediatric Disease Designation for OXi-4503

NEXT STORY
The global therapeutic drug monitoring market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025
PREV STORY
Fluidigm Joins Global Consortium of Cancer Prevention Experts
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Telemedicine Market Size 2021 | Is Anticipated to Exhibit a CAGR of 25.08% and Hit USD 396.76 Billion by 2026

author_avatar
NASDAQ Market News

Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...

author_avatar
NASDAQ Market News

3D Systems Expands Product Lines for Cardiology Training and Surgical Planning

Introduces advanced simulation training for experienced cardiologists Cardiovascular anatomical modeling service provides patient-specific 3D ...

author_avatar
NASDAQ Market News